Article: International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleInternational Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
AuthorsPalumbo, A16
Sezer, O23
Kyle, R7
Miguel, JS28
Orlowski, RZ20
Moreau, P9
Niesvizky, R3
Morgan, G8
Comenzo, R21
Sonneveld, P2
Kumar, S7
Hajek, R19
Giralt, S20
Bringhen, S16
Anderson, KC16 23
Richardson, PG14
Cavo, M10
Davies, F8
Bladé, J1
Einsele, H24
Dimopoulos, MA26
Spencer, A17
Dispenzieri, A7
Reiman, T25
Shimizu, K13
Lee, JH6
Attal, M4
Boccadoro, M16
Mateos, M28
Chen, W27
Ludwig, H18
Joshua, D12
Chim, J22
Hungria, V5
Turesson, I11
Durie, BGM29
Lonial, S15
Issue Date2009
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
CitationLeukemia, 2009, v. 23 n. 10, p. 1716-1730 [How to Cite?]
DOI: http://dx.doi.org/10.1038/leu.2009.122
AbstractIn 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.
ISSN0887-6924
2011 Impact Factor: 9.561
2011 SCImago Journal Rankings: 1.237
DOIhttp://dx.doi.org/10.1038/leu.2009.122
ISI Accession Number IDWOS:000270816300005
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorPalumbo, A
dc.contributor.authorSezer, O
dc.contributor.authorKyle, R
dc.contributor.authorMiguel, JS
dc.contributor.authorOrlowski, RZ
dc.contributor.authorMoreau, P
dc.contributor.authorNiesvizky, R
dc.contributor.authorMorgan, G
dc.contributor.authorComenzo, R
dc.contributor.authorSonneveld, P
dc.contributor.authorKumar, S
dc.contributor.authorHajek, R
dc.contributor.authorGiralt, S
dc.contributor.authorBringhen, S
dc.contributor.authorAnderson, KC
dc.contributor.authorRichardson, PG
dc.contributor.authorCavo, M
dc.contributor.authorDavies, F
dc.contributor.authorBladé, J
dc.contributor.authorEinsele, H
dc.contributor.authorDimopoulos, MA
dc.contributor.authorSpencer, A
dc.contributor.authorDispenzieri, A
dc.contributor.authorReiman, T
dc.contributor.authorShimizu, K
dc.contributor.authorLee, JH
dc.contributor.authorAttal, M
dc.contributor.authorBoccadoro, M
dc.contributor.authorMateos, M
dc.contributor.authorChen, W
dc.contributor.authorLudwig, H
dc.contributor.authorJoshua, D
dc.contributor.authorChim, J
dc.contributor.authorHungria, V
dc.contributor.authorTuresson, I
dc.contributor.authorDurie, BGM
dc.contributor.authorLonial, S
dc.date.accessioned2010-05-31T03:48:39Z
dc.date.available2010-05-31T03:48:39Z
dc.date.issued2009
dc.description.abstractIn 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationLeukemia, 2009, v. 23 n. 10, p. 1716-1730 [How to Cite?]
DOI: http://dx.doi.org/10.1038/leu.2009.122
dc.identifier.citeulike4761024
dc.identifier.doihttp://dx.doi.org/10.1038/leu.2009.122
dc.identifier.epage1730
dc.identifier.hkuros161100
dc.identifier.isiWOS:000270816300005
dc.identifier.issn0887-6924
2011 Impact Factor: 9.561
2011 SCImago Journal Rankings: 1.237
dc.identifier.issue10
dc.identifier.openurl
dc.identifier.pmid19494840
dc.identifier.scopuseid_2-s2.0-70350094381
dc.identifier.spage1716
dc.identifier.urihttp://hdl.handle.net/10722/59372
dc.identifier.volume23
dc.languageeng
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
dc.publisher.placeUnited Kingdom
dc.relation.ispartofLeukemia
dc.relation.referencesReferences in Scopus
dc.subject.meshAntineoplastic Agents - administration and dosage
dc.subject.meshHematopoietic Stem Cell Transplantation
dc.subject.meshMultiple Myeloma - diagnosis - therapy
dc.subject.meshTransplantation, Autologous
dc.titleInternational Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
dc.typeArticle
Author Affiliations
  1. Hospital Clinic Barcelona
  2. Erasmus University Medical Center
  3. Weill Cornell Medical College
  4. Hôpital Purpan
  5. Clinica São Germano
  6. Gachon University of Medicine and Science
  7. Mayo Clinic
  8. Royal Marsden Hospital, London
  9. Centre Hospitalier Universitaire de Nantes
  10. Institute of Hematology and Medical Oncology Seragnoli
  11. Malmö University Hospital
  12. University of Sydney
  13. Nagoya City Midori General Hospital
  14. Dana-Farber Cancer Institute
  15. Emory University
  16. Università degli Studi di Torino
  17. Alfred Hospital
  18. First Dept. of Med./Medical Oncology
  19. Fakultni Nemocnice Brno
  20. University of Texas M. D. Anderson Cancer Center
  21. Tufts Medical Center
  22. Queen Mary Hospital Hong Kong
  23. null
  24. null
  25. Cross Cancer Institute
  26. University of Athens Medical School
  27. Capital Medical University China
  28. Hospital Universitario de Salamanca
  29. Cedars-Sinai Medical Center